Recent studies have revealed that sEVs‐PD‐L1+ derived from tumors are able to suppress antitumor immunity locally and systemically through ligation of PD‐1 on T cells by suppressing their proliferation, survival and effector function and thus facilitating immune escape and tumor progression [14]. This evidence concerns the gene CD274 and neoplasm.